NDT Advance Access published online on October 16, 2008
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfn570
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rab 23 is expressed in the glomerulus and plays a role in the development of focal segmental glomerulosclerosis
1 Graduate Institute of Medical Sciences 2 Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC 3 Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 8 Medical Drive, Singapore 117597 4 Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC
Correspondence and offprint requests to: Ann Chen, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, No. 325, Sec. 2, Cheng-Gung Road, Taipei, Taiwan, ROC. Tel: +886-2-8792-7008; Fax: +886-2-8792-7009; E-mail: doc31717{at}ndmctsgh.edu.tw and Dr. Hao-Ai Shui, Graduate Institute of Medical Sciences, National Defense Medical Center, 161, Min-Chuan East Road, 6th Section, Taipei, Taiwan, ROC. E-mail: haoai{at}ndmctsgh.edu.tw
| Abstract |
|---|
|
|
|---|
Background. Rab23, a member of the Rab family of small GTPase, has a function in antagonizing sonic hedgehog signal transduction. Both Rab-family and hedgehog-related proteins are involved in sclerosis and fibrosis in certain pathological states, but their roles in focal segmental glomerulosclerosis (FSGS) remain unclear.
Methods. The FSGS model was established in Balb/c mice by a single injection of adriamycin. Serum, urine and mice kidneys were collected on Days 0, 7, 15 and 20. Western blot analysis was performed to detect the levels of Rab23 in the samples. Immunohistochemistry was used to examine the expressional profiles of Rab23 in kidneys. The expressions of transcripts of Rab23, extracellular matrix (ECM) proteins, and various hedgehog signalling pathway genes in kidneys or mesangial cells were evaluated by real-time RT-PCR. The effect of Rab23 on ECM protein expressions was evaluated by the knockdown or overexpression of Rab23 in mesangial cells.
Results. Our results show that elevations of Rab23 were observed in the urine, but not in the serum, of the FSGS mice. Rab23 and hedgehog signalling pathway genes were constitutively expressed in normal kidneys and were significantly up-regulated in the kidneys of FSGS mice. The basal expression of Rab23 was identified in glomeruli, and mesangial cells displayed obvious elevation of Rab23 in the FSGS state. The knockdown or overexpression of Rab23 affected the collagen expression in cultured mesangial cells.
Conclusions. An autocrine loop of hedgehog signalling could be activated in mesangial cells in the FSGS state, and Rab23 may be elevated to suppress hedgehog signalling and/or influence collagen synthesis. Importantly, Rab23 could serve as a biomarker that indicates the severity of FSGS.
Keywords: biomarker; focal segmental glomerulosclerosis; hedgehog signal transduction; mesangial cells; Rab23
| Introduction |
|---|
|
|
|---|
Focal segmental glomerulosclerosis (FSGS) is a form of chronic nephropathy characterized by scattered sclerosis of glomeruli in which only a segment of the capillary is affected [1,2]. The molecules involved in FSGS pathogenesis are being gradually uncovered. These include proteins that cause oxidative stress, podocyte damage, hyperfiltration and sclerosis, which lead to marked proteinuria and scattered glomerular sclerosis seen in the disease [2,3]. Occasionally, some proteins that were originally not considered to play any role in FSGS were demonstrated to be involved in the pathogenesis of the disease. For example, osteopontin, a matrixcellular protein with a chemoattractive property for monocytes, has been shown to play a role in epithelial hyperplasia lesion in FSGS [4]. Recently, in our proteomic profiling of FSGS, we have identified Rab23 in the urine of an FSGS mouse model (unpublished data). However, the changes in expressional profiles of Rab23 and its associated genes in FSGS remain unknown.
Rab23 is a member of the large Rab family of small GTPase, which has about 60 members that play varying roles in the intracellular traffic of proteins and membrane vesicles [5–7]. The expression and function of Rab23 in kidneys are unclear. In contrast to Rab23, many other members of the Rab family have been identified in the kidney. Rabs 4, 5, 7, 11, 13, 18, 20, 25, 34 and 38 are located in tubular cells [8–11], while Rab 3A is located in podocytes [12]. Rab11 and Rab20 co-localize with vacuolar H+-ATPase in tubular and intercalated cells and play roles in regulating proton secretion by transferring the H+-ATPase to the plasma membrane [9]. Rab11 also mediates the vasopressin-induced transport of aquaporin-2 water channels to the cell membrane, and therefore plays a role in water re-absorption in collecting duct cells [8]. In particular, Rab3A and Rab38 are two known factors associated with sclerosis and proteinuria in FSGS. Rab3A is expressed in podocytes and changes in its levels correlate with FSGS in mice and proteinuria in patients [12]. A Rab38 mutation causes proteinuria in fawn-hooded hypertensive rats and is associated with a familial form of FSGS in human [13,14].
Unlike the general trafficking function of other Rab family members, Rab23 plays a unique role in regulating the signal transduction of sonic hedgehog, a secreted morphogen that controls the development of multiple organs during embryogenesis [5,15–19]. Hedgehog signalling is initiated by binding of the ligand sonic hedgehog (Shh), desert hedgehog (Dhh) or Indian hedgehog (Ihh) to the receptor patched (PTCH, including PTCH1 and PTCH2). This disinhibits the activity of smoothened (SMO), which then activates glioma-associated oncogene homologue (Gli) transcription factors (including Gli1, Gli2 and Gli3) to turn on the expressions of their target genes [20]. Rab23 appears to antagonize hedgehog signalling, and mutation of Rab23 gene causes a severe defect in the developing neural tube in mice [15,18] and abnormalities of multiple organs in patients of two congenital diseases—Carpenter and Gorlin syndromes [21,22]. In addition, since hedgehog genes, such as shh, possess oncogenic properties [20], Rab23 has been implicated to be involved in carcinogenesis. Indeed, the abnormal expression of Rab23 has been observed in hepatocellular as well as thyroid carcinoma [23,24]; the overexpression of Rab23 has been reported in atrophic gastritis, a pre-stage of gastric cancer [25]. However, although hedgehog-related genes also play roles in fibrosis and/or sclerosis in brain, lung and liver [26–28], the expressional profiles of Rab23 under both of the pathological conditions are still unclear. Similarly, although hedgehog signal transduction participates in kidney development [29,30], the expression of Rab23 in the adult kidney is unknown, especially in the kidney that shows glomerular sclerosis.
Although Rab23 was considered to play a major role in embryogenesis, Rab23 is also found to be highly expressed in adult rodent brain and expressed in low levels in multiple tissues [5,19]. Rab23 may, therefore, have a postnatal physiological function beyond its role in embryonic development. We demonstrated in the present study that Rab23 is elevated in the urine of FSGS mice. Using specific antibodies [19] against Rab23, the expression levels of the protein in normal and FSGS-associated mice were investigated, in conjunction with other hedgehog signalling pathway genes. Our results suggest that Rab23 could play a role in the development of FSGS and could be a marker of FSGS pathology.
| Subjects and methods |
|---|
|
|
|---|
FSGS animal model and sample collections
The experiments were performed using 8-week-old BALB/c mice with the approval of the Institutional Animal Care and Use Committee of the National Defense Medical Center, Taiwan, and were consistent with the NIH Guide for the Care and Use of Laboratory Animals. The mice were injected intravenously with a single dose of adriamycin (AD) (0.1 mg/10 g body weight). Days 0, 7, 15 and 20, which cover different severities of FSGS in the mouse model [3,4,31,32], were chosen for collection of blood and urine samples and for sacrifice of the animals for harvesting of kidneys. Blood was collected through the retro-orbital venous plexus [4,31]. To prevent the degradation of urinary protein and contamination by cellular proteins due to cell lysis, long-period collection of urine was avoided; instead, spot urine was collected at the same time of day on Days 0, 7, 15 and 20. To avoid contamination by food, water and faeces that can happen in using metabolic cages, mouse urine was obtained by gentle bladder massage and collected on a Parafilm film [3]. Serum creatinine, blood urea nitrogen (BUN) and urine protein concentration were then measured.
Measurement of serum creatinine, BUN and urine protein concentration
Samples of serum or urine were cleared by centrifugation and stored in liquid nitrogen until analysis. A modified Bradford method that can minimize interference from urea in urine was used to measure urine protein concentration [33]; Serum creatinine was measured using a picric acid method and BUN was measured using a urease assay as previously described [34].
Histopathology and immunohistochemistry
Renal tissues were fixed in 10% buffered formalin and embedded in paraffin for routine histopathology. Sections of the formalin-fixed renal tissues were immersed in xylene to remove paraffin, rehydrated in graded ethanol, stained with haematoxylin and eosin, and examined under a light microscope (Olympus, Tokyo, Japan). Semi-quantitative analysis of sclerosis was performed with an optical microscope according to our previously published criterion [3,4,31,32].
For single immunostaining of Rab23, OCT-embedded tissues were cut into 5-µm-thick sections. After immersion in acetone for 5 min and air drying, the sections were then incubated with Tris-buffered saline, pH 7.4, containing 0.05% Tween 20 (TBST) and 2% bovine serum albumin (BSA) at room temperature for 30 min for the blocking step. TBST was used for all of the following washing steps. The sections were incubated with a rabbit anti-mouse Rab23 antibody (1:200 dilution) at 4°C overnight, washed with TBST, and incubated with a horseradish peroxidase (HRP)-conjugated goat anti-rabbit antibody (1:200) (Jackson ImmunoResearch, West Grove, PA, USA) at room temperature for 1 h. Bound antibodies were visualized with 3,3'-diaminobenzidine (DAKO, Carpinteria, CA, USA), and the slides were lightly counterstained with haematoxylin. Semi-quantitative analysis of immunohistochemistry (IHC) sections was performed by optical microscope as previously described [4,31,35]. Briefly, fifty glomeruli were examined on each slide, and the Rab23 intensity of glomeruli, podocytes or mesangial cells was assigned a score from 0 to 3. The total intensity score for counted glomeruli, podocytes or mesangial cells was calculated according to the following equation for each specimen: total intensity score = (% intensity negative x 0) + (% intensity trace intensity x 0.5) + (% 1 + intensity x 1) + (% 2 + intensity x 2) + (% 3 + intensity x 3). The values ranged from 0 to a maximum of 300.
For double immunostaining for Rab23/nephrin, the procedure is similar to single immunostaining except that primary antibodies used were rabbit anti-Rab23 (1:150)/goat anti-nephrin (1:20) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and the secondary antibodies used were fluorescein isothiocyanate (FITC)-conjugated donkey anti-rabbit IgG (1:500) (Jackson ImmunoResearch, West Grove, PA, USA)/Alexa Fluor 594-conjugated donkey anti-goat IgG (1:500) (Invitrogen, CA, USA). Semi-quantification of total Rab23 fluorescence intensity was performed using the same equation described above [4,31,35]. For evaluation of the Rab23 expression in podocytes, the area of overlap of the two fluorophores was estimated and presented as a percentage of the total area of glomeruli.
Proteomics analysis
The urine collected by bladder massage was desalted and concentrated by ultrafiltration as previously described [3]. Urinary proteins (400 µg) from the control or FSGS mice were loaded onto an IPG strip (Immobiline DryStrip 3-10, GE Healthcare, NJ, USA) for simultaneous rehydration. Isoelectric focusing and SDS–PAGE were performed according to the protocols previously described [3,36]. The spots were digested with trypsin and subjected to direct mass spectrometry protein identification. The mass spectrometer used for protein analysis was a Bruker Biflex IV MALDI-TOF MS (Bruker Daltonics, Bremen, Germany). Peptide mass fingerprint (PMF) was obtained by averaging signals generated from at least 500 laser shots. The mass spectra were processed using FlexanalysisTM and BiotoolsTM software (Bruker Daltonics, Bremen, Germany) and the data subjected to a search against the UniProt database (http://www.pir.uniprot.org) by the MS-Fit database searching engine (http://prospector. ucsf.edu/ucsfhtml4.0/msfit.htm). For each PMF search, the mass tolerance was set to 100 ppm and one missed tryptic cleavage was allowed.
Cell culture and adriamycin treatment
Mouse mesangial cells CRL-1927 were obtained from the American Type Culture Collection (Rockville, MD, USA) and routinely maintained in a 3:1 mixture of Dulbecco's modified Eagle's medium and Ham's F-12 medium supplemented with 5% fetal bovine serum and 14 mM HEPES as previously described [37]. Cultured mesangial cells (6 x 105 cells/plate) were seeded onto 10-cm diameter plastic dishes before the experiments. After cell attachment, mesangial cells were treated with adriamycin (0–0.2 µg/ml) for 0, 12 or 24 h according to our previous protocol [37]. Then, the cells were harvested for immunocytochemistry, real-time RT-PCR and western blot analysis.
Immunocytochemistry
Harvested CRL-1927 cells were attached onto slide glasses by Cytospin (Cytospin 3, Shandon), and then fixed in 2% paraformaldehyde for 15 min. After blocking with 2% BSA in Tris-buffered saline, cells were treated with an anti-Rab23 antibody (1:200) for 1 h and then incubated with HRP-conjugated goat anti-rabbit IgG (1:200) (Jackson ImmunoResearch, West Grove, PA, USA) for 2 h. Bound antibodies were visualized with 3,3'-diaminobenzidine (DAKO).
Western blot analysis
Urine samples (15 µl for each), serum samples (15 µl for each) or kidney proteins (50 µg) from adriamycin-treated mice (Days 0, 7, 15 and 20) or proteins (50 µg) from cultured mesangial cells were subjected to 10% SDS–PAGE. Proteins were then transferred to a Hybond PVDF membrane (GE Healthcare). The membrane was blocked in a 20 ml blocking buffer (Tris-buffered saline, pH 8.0, containing 0.05% Tween 20 and 5% skimmed milk) at room temperature for 1 h, incubated with a rabbit anti-Rab23 antibody (1:1000) at room temperature for 1 h, and then washed with TBST three times, followed by incubation with the goat anti-rabbit secondary antibody for 1 h at room temperature. The proteins on the membrane were visualized with an ECL detection kit, and protein intensity was quantified by a densitometer. For tissue or cell samples, Rab23 intensity was normalized by the intensity of the internal control GAPDH.
Real-time reverse transcription-polymerase chain reaction (real-time RT-PCR)
Kidney tissues or cultured mesangial cells were subjected to total RNA extraction using Trizol reagent (Life Technologies, Rockville, MD, USA) according to the manufacturer's instruction. For first-strand cDNA synthesis, 3 µg of total RNA was used in a single-round RT reaction, together with 200 ng of random hexamer primer, 0.5 mM dNTPs, 1x first-strand buffer, 5 mM DTT, 10 units of superscript III reverse transcriptase (Invitrogen) in a total volume of 20 µl. PCR was performed using 1 µl of the RT reaction mixture, 0.1 µM of specific primers (Table 1), 1x PCR buffer, 50 µM dNTPs and one unit of KlenTag DNA polymerase in a total volume of 25 µl.
|
Real-time PCR was carried out by the iCycler real-time PCR instrument (Bio-Rad, Hercules, CA, USA), using 10 µl of the RT reaction mixture, 0.07 µM gene-specific primers and 12.5 µl ABsoluteTM QPCR SYBR Green Fluorescein Mix (AB gene, Epsom, UK), in a total volume of 25 µl. The gene-specific primers are listed in Table 1. The thermal cycler conditions were as follows: real-time PCR was initiated by enzyme activation at 95°C for 15 min, followed by 50 cycles of 94°C for 15 s, 55°C for 35 s and 72°C for 60 s and a final extension at 72°C for 10 min. Levels of test genes were normalized to GAPDH mRNA levels by a comparative threshold cycle (2–[delta] Ct) method that converts differences of the cycle numbers to Test gene/GAPDH ratios. Fold changes of mRNA were calculated by a (2–[delta] [delta] Ct) method.
Overexpression and knockdown of Rab23
CRL-1927 mesangial cells were seeded onto 6-cm diameter plastic dishes. The overexpression of Rab23 was performed as previously reported [19]. Briefly, the pCIneo construct carrying full-length Rab23 was transfected into cells using Lipofectamine 2000TM (Invitrogen), and cells were harvested 48 h after the transfection. Knockdown of Rab23 was performed by transfection with a double-stranded small interfering RNA (siRNA) that was made by hybridization of a sense (5'-GAUGCAUGA- AUCAUCCAGCAGAUCGAU-3') RNA oligo and an anti-sense (5'-CGAUCUGCUGGAUGAUUCAAUGCATC-3') RNA oligo.
Statistics
All data are presented as mean ± SEM. Statistical analysis was performed with one-way ANOVA by using the SPSS statistics analysis software program. A Newman–Keuls test was carried out when the ANOVA comparisons gave a significant result. Differences were considered significant at P < 0.05.
| Results |
|---|
|
|
|---|
Pathophysiological manifestations exhibited by mice in the FSGS model
Consistent with our previous reports [3,4,31,32], severe proteinuria and deteriorated renal clearance function were exhibited by the adriamycin-treated mice. Compared to basal levels (0.59 ± 0.082 mg/ml), the urine protein levels were significantly elevated on Day 15 (16.84 ± 3.13 mg/ ml) (F = 13.81, P < 0.01) (Figure 1A). Serum creatinine and BUN, two general parameters for evaluating renal function, were also higher in adriamycin-treated mice compared to control mice. Serum creatinine showed significant elevations on Day 15 (2.02 ± 0.17 mg/dl versus the basal levels of 0.48 ± 0.03 mg/dl; F = 25.17, P < 0.01) (Figure 1B), and BUN also showed significant increases on Day 15 (71.42 ± 8.09 mg/dl versus the basal levels of 21.85 ± 1.99 mg/dl; F = 38.79, P < 0.01) (Figure 1C).
|
Glomerular sclerosis in the FSGS model
Histopathological examination was performed on kidney sections obtained on Days 0, 7, 15 and 20. As shown in Figure 2A, expansion of the extracellular matrix (ECM) and deposition of hyaline mass in the glomeruli were obvious in FSGS mice in comparison to the control mice. Sclerosis scores were significantly higher in FSGS mice than in control mice on Day 7 (13.17 ± 2.06 compared to basal levels of 0.0 ± 0.0; F = 74.48, P < 0.01) and continued to elevate on Day 15 (63.83 ± 6.20 compared to the basal levels; F = 74.48, P < 0.01) and Day 20 (76.83 ± 5.75 compared to the basal levels; F = 74.48, P < 0.01) (Figure 2B). The extent of sclerosis correlated well with the severity of the clinical manifestations as shown in Figure 1.
|
Identification of Rab23 in urine from FSGS mice by proteomic analysis
We have previously reported serial changes of urinary proteome in FSGS mice [3] based on more abundant proteins. However, after the concentration of the urine proteins, we have now identified a new spot corresponding to Rab23 in 2D gels of urine from FSGS mice (white arrow in Figure 3A, right panel) that was absent (undetectable) in gels of control mice (left panel). The peptide mass fingerprint of the identified protein matches 10 peptides that cover 46.4% Rab23 amino acid sequence (Figure 3B). The expression of Rab23 during FSGS has never been identified by our or other labs proteomics work. In contrast, most of other spots shown in Figure 3 have been published in our recent paper [3].
|
Serial increase of Rab23 levels in mouse urine during FSGS
In order to confirm the identification of Rab23, we used the specific anti-mouse Rab23 antibody [19] to perform western blot analysis of the concentrated urine proteins. As shown in Figure 4, urine Rab23 protein can be detected by western blot analysis in FSGS mice on Days 7, 15 and 20, but undetectable on Day 0 when FSGS was absent (F = 26.18, P < 0.01). The Rab23 levels increased with the progression and severity of FSGS in mice (Figure 4 versus Figure 2; Figure 4 versus Figure 1). In addition, blood is unlikely to be the source of urine Rab23 protein as Rab23 was not detectable in mouse serum at any stage of FSGS (Figure 4A).
|
Increases of Rab23 expression in mouse kidneys during FSGS
In order to delineate the source of urinary Rab23, we checked both mRNA and protein expressions levels of Rab23 in kidneys of the FSGS mice. As shown in Figure 5A, renal Rab23 mRNA levels on Day 7 (0.12 ± 0.019), Day 15 (0.18 ± 0.028) and Day 20 (0.27 ± 0.059) were significantly higher than those on Day 0 (0.013 ± 0.0025) (F = 9.85, P < 0.01), again correlating with the increase in severity of FSGS. Similarly, renal Rab23 protein levels on Day 7 (0.61 ± 0.078), Day 15 (1.02 ± 0.11) and Day 20 (0.93 ± 0.090) were also significantly higher than those on Day 0 (0.24 ± 0.028) (F = 19.18, P < 0.01), indicating that kidney tissues could be a major source of urinary Rab23 protein in FSGS mice.
|
Localizing Rab23 expression in mouse kidneys
In order to determine the tissue/cell location of Rab23 expression in kidneys, we performed single and double immunostaining to respectively evaluate Rab23 expression based on counting colour and fluorescence intensity scores.
Figure 6A shows the semi-quantitative data of single immunohistochemical stain. Total intensity scores of Rab23 in glomeruli were elevated on Days 7, 15 and 20 (139.50 ± 19.93, 202.33 ± 18.20 and 208.50 ± 23.91, respectively), significantly higher than those on Day 0 (61.83 ± 7.86) (F = 14.12, P < 0.01). Similarly, the expression levels of mesangial Rab23 in FSGS mice on Days 7, 15 and 20 (145.33 ± 17.83, 189.33 ± 21.63, and 181.83 ± 25.07, respectively) were significantly higher than those of control mice on Day 0 (67.33 ± 4.72) (F = 8.65, P < 0.01) (Figure 6A), correlating well with the increases of Rab23 transcripts (real-time RT-PCR) and protein (western blot analysis) shown above (Figure 5). The expression of Rab23 was also noticed in the podocytes (black arrows in the tissue sections, Figure 6A), but these did not show a significant elevation in FSGS mice on Day 7, 15 or 20 in comparison to the control mice (39.83 ± 3.95) (F = 1.53, P > 0.05).
|
Figure 6B shows the semi-quantitative data of double immunostaining of Rab23/nephrin. Consistent with Figure 6A, counting of the fluorescence intensity of total glomerular Rab23 showed that total Rab23 expression elevated along the course of FSGS disease progression (F = 6.62, P < 0.05). However, the major areas of Rab23 elevation do not coincide with nephrin staining. Indeed, based on calculating the overlapping fluorescent areas of Rab23/nephrin, a mild but not significant (F = 0.514, P > 0.05) elevation of Rab23 was observed in the nephrin-positive area.
Constitutive expression of Rab23 and hedgehog signalling pathway genes in mesangial cells
Since Rab23 elevation can only be observed in mesangial cells in FSGS mice, we wondered whether it is merely a drug response to adriamycin stimulation.
In order to confirm the Rab23 expression in glomeruli mesangial cells, we analysed Rab23 expression in a mesangial cell line. In addition, since Rab23 is known to play a role in regulating hedgehog signal transduction, we, therefore, also checked the expressions of hedgehog signalling pathway genes in the mesangial cell line. As shown in Figure 7, constitutive expression of Rab23 can be observed in the mouse mesangial cell line CRL-1927 (immunocytochemistry in Figure 7A, 0 h bar in Figure 7B, and 0 h lane in Figure 7C) and basal constitutive expression of Shh, Ihh, Dhh, PTCH1, PTCH2, SMO, Gli1, Gli2 and Gli3 can also be detected in these cells (0 hr bars in Figure 7D).
|
As shown in Figure 7B and C, the expressions of both mRNA and protein of Rab23 did not change significantly after adriamycin (0–0.2 µg/ml) treatment for 24 h (F = 1.315 and 0.029, respectively, P > 0.05). We can, therefore, rule out an immediate and direct drug-elicited effect by adriamycin on Rab23 expression in the cells. Similarly, in Figure 7D, the expressions of hedgehog signalling pathway genes (Shh, Ihh, Dhh, PTCH1, PTCH2, SMO, Gli1, Gli2 and Gli3) were not significantly altered by adriamycin (0–0.2 µg/ml) treatment of the mesangial cell line (F = 0.011, 1.54, 1.79. 1.43, 0.32, 0.97, 0.58, 2.30, and 0.22, respectively, P > 0.05).
Expressional profiles of hedgehog signalling pathway genes in kidneys of FSGS mice
The expression of Rab23 and hedgehog signalling-related genes in adult kidneys has never been studied before. We, therefore, profiled the expression of these hedgehog signalling-related genes in the kidneys of both control and FSGS mice. As shown in Figure 8, the expressions of all genes of the hedgehog signalling pathway can be detected in kidneys of the normal control mice on Day 0, indicating that these genes are constitutively expressed in normal adult mice kidneys. This finding is interesting as the developmentally regulated hedgehog signalling genes were not expected to be expressed in high levels in adult kidneys.
|
Upon induction of FSGS, the expressions of Ihh, SMO and Gli3 were significantly enhanced by Day 15 and Day 20 (F = 7.96, 5.90 and 8.21, respectively, P < 0.01), while the expressions of Shh, Dhh, Gli1, Gli2, PTCH1 and PTCH2 remained unchanged (F = 1.18, 2.66, 0.17, 2.10, 2.59 and 2.33, respectively, P > 0.05) (Figure 8). The changes of the expression of the hedgehog signalling pathway genes indicated that hedgehog signalling could be activated in the FSGS state compared to the control state.
Effects of Rab23 on the expressions of ECM proteins in mesangial cells
To check whether Rab23 can affect ECM protein expression in mesangial cells, we manipulated Rab23 expression in the cells and then checked whether the expressions of fibronectin and collagens can be affected. As shown in Figure 9, the knockdown and overexpression of Rab23 by transfections with siRNA and with a Rab23 expression construct can respectively cause down-regulation and up-regulation of collagen type 1A2 (P < 0.05), whereas the expressions of fibronectin and other types of collagen were not affected (P > 0.05). This result indicates that Rab23 might contribute to FSGS by affecting the synthesis of certain ECM proteins.
|
| Discussion |
|---|
|
|
|---|
In our investigations based on a lead target revealed by proteomic analysis of urine, we found that Rab23 is expressed in podocytes and mesangial cells within glomeruli. Rab23 elevation allowed its detection in the urine, probably through release by damage of both cells. We infer that mesangial Rab23 could play a more crucial role in FSGS than podocyte Rab23, as the FSGS-associated change of Rab23 expression is observed only in the mesangial cells, rather than the podocytes for different severities (Days 0, 7, 15 and 20) of FSGS. However, we did not study the very late FSGS stages such as Week 6 shown by some literatures [38–40], as mice in that stage could have significant systemic problems, which change the urine protein profile and lead to misinterpretation of our data [32].
Mesangial cells are known to play significant roles in the sclerosis of FSGS [41]. These cells are located among glomerular capillaries, providing support and regulating glomerular blood flow by their contractile activity [37]. In addition, mesangial cells can perform phagocytosis [42,43], as well as secretion [31] of various ECM proteins (such as collagen, fibronectin and laminin) to affect glomerular ECM compositions. Accordingly, mesangial cells can control glomerular filtration and ECM protein deposition that contribute, respectively, to proteinuria and sclerosis under the pathological condition of FSGS. In the present study, we have made the novel finding that Rab23 is constitutively expressed in mesangial cells and is up-regulated in the FSGS state. The finding suggests that Rab23 might somehow influence the physiological activities of mesangial cells and play roles in the development of FSGS. Although the roles of Rab23 in mesangial cells and in FSGS are still unclear, they can be speculatively deduced from literature addressing Rab23 functions in other cell types.
Rab23, like other members in the Rab family, is likely to function in some aspect of the trafficking of intracellular proteins [5–7] and could be involved in endocytosis or exocytosis [19,44]. Although Rab23 is known to regulate sonic hedgehog signalling during development, the protein that is transported by Rab23 in the hedgehog signalling pathway remains unidentified [5]. Likewise, although Rab23 is expressed in high abundance in neurons of adult mouse brains, transport pathways and cargoes that are regulated by Rab23 in neurons are also unknown [5,19]. However, using HeLa cells phagocytosis of mutant S. Typhimurium as a model system, Rab23 has been demonstrated to be involved in the phagocytic membrane traffic [44]. Since Rab23 is constitutively expressed in mesangial cells (Figures 6A and 7A–C), Rab23 could control the traffic of cargo proteins whose physiological functions are essential to mesangial cells. However, since Rab23 expression is up-regulated in mesangial cells in the FSGS state (Figures 5 and 6), some of the proteins that are transported by Rab23 in mesangial cells might also play a role in the development, or disease progress, of FSGS. Mesangial cells have been reported to be capable of phagocytosing many extracellular proteins, including immune complexes, growth factors and ECM proteins [42,43]. Since phagocytosis of ECM proteins can influence the development of sclerosis in FSGS, future investigations should address whether Rab23 is involved in the phagocytosis function of mesangial cells.
Rab23 expression can apparently influence cell proliferation. Recently, some reports have shown that the overexpression of Rab23 can be observed in certain types of cancers [23–25]. Knockdown of Rab23 expression can actually inhibit the growth of hepatocarcinoma cells [23], implicating that Rab23 has a proliferation-promoting effect, at least in hepatomas. However, since Rab23 can block hedgehog signal transduction [5,20] that is growth promoting in certain cancer cells [45–47], Rab23 might also be anti-proliferative for certain cells. Excessive proliferation of mesangial cells is a common phenomenon observed in various types of nephropathy [48,49], which disrupts the delicate structure of glomeruli and affects their filtration function. Although proliferation of mesangial cells in FSGS is not as significant as other forms of acute nephropathies [48,49], it can occasionally be observed in the tissue sections of FSGS kidneys (data not shown). The proliferative state of mesangial cells might affect severity of sclerosis as proliferation can increase the number of the cells that are able to phagocytise and secrete ECM proteins, thus affecting the ECM deposition. Future studies would address whether Rab23 and hedgehog signal transduction can influence the proliferation rate of mesangial cells.
The hedgehog signal transduction is initiated by the binding of Shh, Dhh or Ihh to the receptor PTCH, a repressor of SMO. This results in the disinhibition of SMO, which in turn activates the Gli transcription factors and downstream target genes [20]. Secreted hedgehogs play both autocrine and paracrine roles in embryogenesis and carcinogenesis [45–47] and also play pathogenic roles in fibrosis and/or sclerosis in certain organs [26–28]. Since both the ligands (Shh, Dhh and Ihh) and receptors (PTCH1 and PTCH2) are expressed in mesangial cells (Figure 7D), an autocrine role of the mesangial-derived hedgehog is possible. In addition, since Rab23 is a negative regulator of hedgehog signalling [5,15–19], the constitutive expression of Rab23 in mesangial cells (Figure 7A–C) could play a negative counterbalancing role in modulating hedgehog signalling in these cells. Since Rab23 and some of the hedgehog signalling pathway genes were up-regulated in FSGS kidneys (Figures 5, 6 and 8), the predicted autocrine action of hedgehog in mesangial cells might be activated in the FSGS state and may play a role in the development and progression of the disease.
The exact mechanisms underlying the up-regulation of Rab23 and hedgehog signalling pathway genes in FSGS are still unclear. The elevated proteins could play either a protective or a pathogenic role in FSGS development. What is clear is that the up-regulation of the genes is not caused by adriamycin directly, as the phenomenon was not observed in adriamycin-treated mesangial cell line (Figure 7). Since Rab23 levels in both kidney tissue and urine correlated with the severity of FSGS (Figures 4–6 versus Figures 1 and 2), Rab23 is a potential biomarker of chronic nephropathies. Since the knockdown or overexpression of Rab23 can affect the collagen expression in cultured mesangial cells (Figure 9), Rab23 may contribute to FSGS by influencing ECM protein deposition.
In conclusion, using various approaches, we have demonstrated that Rab23 and hedgehog signalling pathway genes were constitutively expressed in podocytes and mesangial cells and were up-regulated in mesangial cells in the FSGS state. Based on the data, we suggested that an autocrine loop of the hedgehog signalling pathway could be activated in mesangial cells during FSGS in mice, and Rab23 could play a feedback role in suppressing the activated hedgehog signalling transduction. Importantly, Rab23's elevation in FSGS could serve as a biomarker for chronic nephropathies.
| Conflict of interest statement |
|---|
|
|
|---|
None declared.
| Acknowledgments |
|---|
This work was supported by grants NSC 97-2320-B-016-010-MY3, NSC 96-2320-B-016-011-MY3 and NSC 96-2320-B-016-012-MY2 from the National Science Council, Taiwan, ROC. B.L.T. is supported by a grant (R-183-000-102-112) from the Ministry of Education, Singapore, and the academic staff research fund, National University of Singapore. T.H.H. is supported by a grant (EZRPF-360221-09511N023) from Chang-Gung Institute of Technology, Taiwan, ROC. H.A.S. is supported by a grant (DOH97-TD-I-111-TM022) from Department of Health, Executive Yuan, Taiwan, ROC.
| References |
|---|
|
|
|---|
- Benchimol C. Focal segmental glomerulosclerosis: pathogenesis and treatment. Curr Opin Pediatr (2003) 15:171–180.[CrossRef][Web of Science][Medline]
- Fogo AB. Animal models of FSGS: lessons for pathogenesis and treatment. Semin Nephrol (2003) 23:161–171.[CrossRef][Web of Science][Medline]
- Shui HA, Huang TH, Ka SM, et al. Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis. Nephrol Dial Transplant (2008) 23:176–185.
[Abstract/Free Full Text] - Shui HA, Ka SM, Yang SM, et al. Osteopontin as an injury marker expressing in epithelial hyperplasia lesions helpful in prognosis of focal segmental glomerulosclerosis. Transl Res (2007) 150:216–222.[CrossRef][Web of Science][Medline]
- Wang Y, Ng EL, Tang BL. Rab23: What exactly does it traffic? Traffic (2006) 7:746–750.[CrossRef][Web of Science][Medline]
- Pfeffer SR. Structural clues to Rab GTPase functional diversity. J Biol Chem (2005) 280:15485–15488.
[Abstract/Free Full Text] - Stenmark H, Olkkonen VM. The Rab GTPase family. Genome Biol (2001) 2. reviews 3007.
- Barile M, Pisitkun T, Yu MJ, et al. Large scale protein identification in intracellular aquaporin-2 vesicles from renal inner medullary collecting duct. Mol Cell Proteomics (2005) 4:1095–1106.
[Abstract/Free Full Text] - Curtis LM, Gluck S. Distribution of Rab GTPases in mouse kidney and comparison with vacuolar H+-ATPase. Nephron Physiol (2005) 100:31–42.[CrossRef]
- Speight P, Silverman M. Diacylglycerol-activated Hmunc13 serves as an effector of the GTPase Rab34. Traffic (2005) 6:858–865.[CrossRef][Web of Science][Medline]
- Tajika Y, Matsuzaki T, Suzuki T, et al. Differential regulation of AQP2 trafficking in endosomes by microtubules and actin filaments. Histochem Cell Biol (2005) 124:1–12.[CrossRef][Web of Science][Medline]
- Rastaldi MP, Armelloni S, Berra S, et al. Glomerular podocytes possess the synaptic vesicle molecule Rab3A and its specific effector rabphilin-3a. Am J Pathol (2003) 163:889–899.
[Abstract/Free Full Text] - Osanai K, Takahashi K, Nakamura K, et al. Expression and characterization of Rab38, a new member of the Rab small G protein family. Biol Chem (2005) 386:143–153.[CrossRef][Web of Science][Medline]
- Rangel-Filho A, Sharma M, Datta YH, et al. RF-2 gene modulates proteinuria and albuminuria independently of changes in glomerular permeability in the fawn-hooded hypertensive rat. J Am Soc Nephrol (2005) 16:852–856.
[Free Full Text] - Eggenschwiler JT, Bulgakov OV, Qin J, et al. Mouse Rab23 regulates hedgehog signaling from smoothened to Gli proteins. Dev Biol (2006) 290:1–12.[CrossRef][Web of Science][Medline]
- Evans TM, Simpson F, Parton RG, et al. Characterization of Rab23, a negative regulator of sonic hedgehog signaling. Methods Enzymol (2005) 403:759–777.[Web of Science][Medline]
- Evans TM, Ferguson C, Wainwright BJ, et al. Rab23, a negative regulator of hedgehog signaling, localizes to the plasma membrane and the endocytic pathway. Traffic (2003) 4:869–884.[CrossRef][Web of Science][Medline]
- Eggenschwiler JT, Espinoza E, Anderson KV. Rab23 is an essential negative regulator of the mouse Sonic hedgehog signalling pathway. Nature (2001) 412:194–198.[CrossRef][Web of Science][Medline]
- Guo A, Wang T, Ng EL, et al. Open brain gene product Rab23: expression pattern in the adult mouse brain and functional characterization. J Neurosci Res (2006) 83:1118–1127.[CrossRef][Web of Science][Medline]
- Ruiz i Altaba A. Gli proteins and Hedgehog signaling: development and cancer. Trends Genet (1999) 15:418–425.[CrossRef][Web of Science][Medline]
- Oostra RJ, Maas M. Bifid ribs and unusual vertebral anomalies diagnosed in an anatomical specimen. Gorlin syndrome? Am J Med Genet A (2006) 140:2135–2138.[Medline]
- Jenkins D, Seelow D, Jehee FS, et al. Rab23 mutations in Carpenter syndrome imply an unexpected role for hedgehog signaling in cranial-suture development and obesity. Am J Hum Genet (2007) 80:1162–1170.[CrossRef][Web of Science][Medline]
- Liu YJ, Wang Q, Li W, et al. Rab23 is a potential biological target for treating hepatocellular carcinoma. World J Gastroenterol (2007) 13:1010–1017.[Web of Science][Medline]
- Denning KM, Smyth PC, Cahill SF, et al. A molecular expression signature distinguishing follicular lesions in thyroid carcinoma using preamplification RT-PCR in archival samples. Mod Pathol (2007) 20:1095–1102.[CrossRef][Web of Science][Medline]
- Kim KR, Oh SY, Park UC, et al. Gene expression profiling using oligonucleotide microarray in atrophic gastritis and intestinal metaplasia. Korean J Gastroenterol (2007) 49:209–224.[Medline]
- Mastronardi FG, daCruz LA, Wang H, et al. The amount of sonic hedgehog in multiple sclerosis white matter is decreased and cleavage to the signaling peptide is deficient. Mult Scler (2003) 9:362–371.
[Abstract/Free Full Text] - Sicklick JK, Li YX, Choi SS, et al. Role for hedgehog signaling in hepatic stellate cell activation and viability. Lab Invest (2005) 85:1368–1380.[CrossRef][Web of Science][Medline]
- Stewart GA, Hoyne GF, Ahmad SA, et al. Expression of the developmental Sonic hedgehog (Shh) signalling pathway is up-regulated in chronic lung fibrosis and the Shh receptor patched 1 is present in circulating T lymphocytes. J Pathol (2003) 199:488–495.[CrossRef][Web of Science][Medline]
- Yu J, Carroll TJ, McMahon AP. Sonic hedgehog regulates proliferation and differentiation of mesenchymal cells in the mouse metanephric kidney. Development (2002) 129:5301–5312.[Web of Science][Medline]
- Zhang L, Hua F, Yuan GH, et al. Sonic hedgehog signaling is critical for cytodifferentiation and cusp formation in developing mouse molars. J Mol Histol (2007).
- Shui HA, Ka SM, Lin JC, et al. Fibronectin in blood invokes the development of focal segmental glomerulosclerosis in mouse model. Nephrol Dial Transplant (2006) 21:1794–1802.
[Abstract/Free Full Text] - Chen A, Sheu LF, Ho YS, et al. Experimental focal segmental glomerulosclerosis in mice. Nephron (1998) 78:440–452.[CrossRef][Web of Science][Medline]
- Ramagli LS. Quantifying protein in 2-D PAGE solubilization buffer. In: Link, AJ, ed. 2-D Proteome analysis protocols. (1999) Humana Press, Totowa, NJ. 99–103.
- Montinaro V, Hevey K, Aventaggiato L, et al. Extrarenal cytokines modulate the glomerular response to IgA immune complexes. Kidney Int (1992) 42:341–353.[CrossRef][Web of Science][Medline]
- Ka SM, Rifai A, Chen JH, et al. Glomerular crescent-related biomarkers in a murine model of chronic graft versus host disease. Nephrol Dial Transplant (2006) 21:288–298.
[Abstract/Free Full Text] - Shui HA, Ho ST, Wang JJ, et al. Proteomic analysis of spinal protein expression in rats exposed to repeated intrathecal morphine injection. Proteomics (2007) 7:796–803.[CrossRef][Web of Science][Medline]
- Jin JS, Yao CW, Chin TY, et al. Adriamycin impairs the contraction of mesangial cells through the inhibition of protein kinase C and intracellular calcium. Am J Physiol Renal Physiol (2004) 287:F188–F194.
[Abstract/Free Full Text] - Vielhauer V, Berning E, Eis V, et al. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Kidney Int (2004) 66:2264–2278.[CrossRef][Web of Science][Medline]
- Wang Y, Wang YP, Tay YC, et al. Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int (2000) 58:1797–1804.[CrossRef][Web of Science][Medline]
- Wang Y, Wang YP, Tay YC, et al. Role of CD8(+) cells in the progression of murine adriamycin nephropathy. Kidney Int (2001) 59:941–949.[CrossRef][Web of Science][Medline]
- Cornacchia F, Fornoni A, Plati AR, et al. Glomerulosclerosis is transmitted by bone marrow-derived mesangial cell progenitors. J Clin Invest (2001) 108:1649–1656.[CrossRef][Web of Science][Medline]
- Mancilla-Jimenez R, Bellon B, Kuhn J, et al. Phagocytosis of heat-aggregated immunoglobulins by mesangial cells: an immunoperoxidase and acid phosphatase study. Lab Invest (1982) 46:243–253.[Web of Science][Medline]
- Cosio FG, Sedmak DD, Nahman NS Jr. Cellular receptors for matrix proteins in normal human kidney and human mesangial cells. Kidney Int (1990) 38:886–895.[Web of Science][Medline]
- Smith AC, Heo WD, Braun V, et al. A network of Rab GTPases controls phagosome maturation and is modulated by Salmonella enterica serovar Typhimurium. J Cell Biol (2007) 176:263–268.
[Abstract/Free Full Text] - Yuan Z, Goetz JA, Singh S, et al. Frequent requirement of hedgehog signaling in non-small cell lung carcinoma. Oncogene (2007) 26:1046–1055.[CrossRef][Web of Science][Medline]
- Zhang J, Lipinski R, Shaw A, et al. Lack of demonstrable autocrine hedgehog signaling in human prostate cancer cell lines. J Urol (2007) 177:1179–1185.[CrossRef][Web of Science][Medline]
- Zhu G, Zhau HE, He H, et al. Sonic and desert hedgehog signaling in human fetal prostate development. Prostate (2007) 67:674–684.[CrossRef][Web of Science][Medline]
- Baker AJ, Mooney A, Hughes J, et al. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest (1994) 94:2105–2116.[Web of Science][Medline]
- Shui HA, Ka SM, Wu WM, et al. LPS-evoked IL-18 expression in mesangial cells plays a role in accelerating lupus nephritis. Rheumatology (Oxford) (2007) 46:1277–1284.[CrossRef][Medline]
Accepted in revised form: 18. 9.08
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||








